0 followers
Proterris, a P2 clinical-stage firm, has pooled a dominant IP position in therapeutic uses of inhaled and small-molecule carbon monoxide.
Jeffrey Wager
Thermo Fisher Scientific
155 followers
Alexion Pharmaceuticals
34 followers
NeoGenomics
8 followers
Bon Secours Mercy Health
4 followers
Elevance Health
124 followers
Alector
3 followers
Merck
211 followers
BioAgilytix
1 follower
Ventyx Biosciences
1 follower
Pyxis Oncology
1 follower
Optum
46 followers
Explore companies